EMA — authorised 30 May 2020
- Marketing authorisation holder: Novartis Europharm Limited
- Status: approved
🇪🇺 Elocon in European Union
EMA authorised Elocon on 30 May 2020
Marketing authorisation
Elocon in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is Elocon approved in European Union?
Yes. EMA authorised it on 30 May 2020.
Who is the marketing authorisation holder for Elocon in European Union?
Novartis Europharm Limited holds the EU marketing authorisation.